Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features

Natalya Avtandilovna Raspopina; Shuganov Evgeny Grigoryevich; Salmasi Jean Mustafaevich; Shuganov Altxander Evgenyevich; Popova Elena Nikolaevna; Subbotina Tatyana Igorevna; Filippova Tamara Vladimirovna

doi:doi:10.11648/j.ajim.20210903.17

Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features

Natalya Avtandilovna Raspopina, Shuganov Evgeny Grigoryevich, Salmasi Jean Mustafaevich, Shuganov Altxander Evgenyevich, Popova Elena Nikolaevna, Subbotina Tatyana Igorevna, Filippova Tamara Vladimirovna

Published in American Journal of Internal Medicine (Volume 9, Issue 3)

Received: 25 April 2021 Accepted: 18 May 2021 Published: 7 June 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Among respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD) are the most common. Considering that the leading clinical symptom of these diseases is bronchial obstruction, as well as a large number of phenotypes in both asthma and COPD, especially when patients have signs of both diseases, problems arise in differential diagnosis. Immune inflammation plays an important pathological role in chronic obstructive pulmonary disease and asthma. Lymphocyte is the principal immune cell capable of recognizing a particular molecular determinant of the organic structure disorder. We aimed to search for specific features of the immune response in these diseases. Therefore, we determined in peripheral blood the relative and absolute content of lymphocytes expressing the CD3, CD4, CD16, CD54, CD56, CD72, HLA-DR, CD95, and CD178 antigens. The study found that low CD8, CD16 and high CD 178 lymphocytes are characteristic of patients with asthma, and high CD8, CD16 and low CD 178 are typical in COPD. Over 4-5 times increase in CD54 is characteristic of asthma, while in COPD the index exceeded the norm by only 50%. An important feature of COPD is a low apoptosis irrespective of the stage of the disease. These immunologic features can be additional criteria for asthma and COPD differentiation.

Published in	American Journal of Internal Medicine (Volume 9, Issue 3)
DOI	10.11648/j.ajim.20210903.17
Page(s)	148-152
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Asthma, Chronic Obstructive Pulmonary Disease, Differential Diagnosis, Immune Inflammation, Cytotoxic Lymphocytes, CD Antibodies

References

[1]	Aysanov Z. R., Avdeev S. N., Arkhipov V. V., Belevsky A. S., Leshchenko I. V., Ovcharenko S. I., Shmelev E. I., Chuchalin A. G. National clinical guidelines for the diagnosis and treatment of COPD: an algorithm for making clinical decisions. Pulmonology 2017; 27 (1): 13-20. (In Russ)] https://doi.org/10.18093/0869-0189-2017-27-1-13-20.
[2]	Global Strategy for Asthma Management and Prevention. Revised 2018 // www.ginasthma.com.
[3]	Anaev E. Kh.. Biological Markers of Chronic Obstructive Pulmonary Disease. Practical pulmonology 2018: 1: 26-31. http://atmosphere-ph.ru (In Russ).
[4]	Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, der Zee AH, Koenderman L. Clinical utility of asthma biomarkers: from bench to bedside. Biologics: Targets and Therapy 2013: 7 199–210. https://doi.org/10.2147/BTT.S29976.
[5]	Raspopina N. Ah. Shukanov A. E., Paleev F. N., Salmasi Zh. M., Kazimir A. N. The role of cytotoxic lymphocytes in inflammation in COPD patients in the stage of exacerbation and remission. Almanac of clinical medicine. 2014; 35, 49-53. (In Russ) https://doi.org/10.18786/2072-0505-2014-35-49-53.
[6]	Poryadin G. V., Salmasi Zh. M., Makarkov A. I. «Mechanism of regulation of expression of surface structures of differentiated lymphocyte. Immunology. 1997: 3: 4-8. (In Russ).
[7]	Nikoletta Rovina, Antonia Koutsoukou, Nikolaos G. Koulouris. Inflammation and Immune Response in COPD: Where Do We Stand?. Mediators of Inflammation vol. 2013 on p. 1- 9., Article ID 413735 https://doi.org/10.1155/2013/413735.
[8]	Won-Dong Kim, Hyun-Sook Chi, Kang-Hyeon Choe, Yeon-Mok Oh, Sang-Do Lee, Kyu-Rae Kim, Kwang-Ha Yoo, David A. Ngan, W. Mark Elliott, David J. Granville, Don D. Sin, James C. Hogg A possible role for CD8+ and non-CD8+ cell granzyme B in early small airway wall remodelling in centrilobular emphysema,” Respirology, vol. 18, no. 4, pp. 688–696, 2013. https://doi.org/10.1111/resp.12069.
[9]	Poryadin G. V., Salmasi Zh. M., Kazimirsky A. N. Comparative characteristics of markers of Fas-dependent apoptosis in patients with bronchial asthma and COPD. Russian journal of immunology, 2013: 7 (2-3), 207 (In Russ).
[10]	Poryadin G. V., Salmasi Zh. M., Kazimirsky A. N., Semenova L. Yu. Immunopathogenesis of atopic diseases. Bulletin of Siberian medicine 2017; 16 (4): 233-241. (In Russ)] https://doi.org/10.20538/1682-0363-2017-4-233-241.
[11]	Chapman K. R., Boulet L. P., Rea R. M., Franssen E. Supoptimal asthma control: prevalence detection and consequence in general practice. Eur. Respir. J. 2008; 31 (2): 320-325 https://doi.org/10.1183/ 09031936. 00039707.
[12]	Culley F. J. Natural killer cells in infection and inflammation of lung. //Immunology. 2009, 128 (2): 51-163. https://doi.org/10.1111/j.1365-2567.2009.03167.x.
[13]	Poryadin G. V., Orsanco M. A., Salmas J. M., Kazimirsky A. N. "Activation processes in lymphocytes of patients with latent sensitization", "Pathological physiology and experimental therapy". 2009: 1, 23-24 (In Russ) https://doi.org/10.21518/2079-701x-2019-8-76-82.
[14]	Polverino F, Baraldo S, Bazzan E, Agostini S, Turato G, Lunardi F, Balestro E, Damin M, Papi A, Maestrelli P, et al. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med 2010; 182: 1011–1019. DOI: https://doi.org/10.4049/jimmunol.172.8.4661.
[15]	Culley F. J. Natural killer cells in infection and inflammation of lung. Immunology. 2009, 128 (2): 51-163. https://doi.org/10.1111/j.1365-2567.2009.03167.x.
[16]	Folli C., Chiappori A., Pellegrini M., Garelli V., Riccio A. M. et al «COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their INF-y secretion. Pulm. Pharmacol. Ther. 2012; 25 (5): 371-6. https://doi.org/10.1016/j.pupt.2012.06.009.
[17]	Rijivec M., Volarevic S., Osolnik K., Korosec P. Natural killer T cell in pulmonary disorders. Respir. Med., 2011, 105 Suppl 1 S20-5. https://doi.org/10.1016/s0954-6111(11)70006-3.
[18]	Katchar K, Wahlstron A., Soderston J., Eklund J. Характеристика естественных киллеров и CD 56 Т –клеток у пациентов с саркоидозом. Eur. Respir. J. 2005; 26: 77-85. [K. Katchar, Wahlstron A., Soderston J., Eklund J. Characterization of natural killer cells and CD 56 T cells in patients with sarcoidosis. Eur. Respir. J. 2005; 26: 77-85.] https://doi.org/10.1183/09031936.05.00030805.
[19]	Kongning Li, Deng Wu, Xi Chen, Ting Zhang, Lu Zhang, Ying Yi, Zhengqiang Miao, Nana Jin Xiaoman Bi, Hongwei Wang, Jianzhen Xu, and Dong Wang. Current and Emerging Biomarkers of Cell Death in Human Disease. BioMed Research International Volume 2014, Article ID 690103, 10. http://dx.doi.org/10.1155/2014/690103.
[20]	Ji Heui Kim and Yong Ju Jang Role of Natural Killer Cells in Airway Inflammation. Allergy Asthma Immunol Res. 2018 Sep; 10 (5): 448–456. http://dx.doi: 10.4168/aair.2018.10.5.448.

Cite This Article

Plain Text BibTeX RIS

APA Style

Natalya Avtandilovna Raspopina, Shuganov Evgeny Grigoryevich, Salmasi Jean Mustafaevich, Shuganov Altxander Evgenyevich, Popova Elena Nikolaevna, et al. (2021). Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. American Journal of Internal Medicine, 9(3), 148-152. https://doi.org/10.11648/j.ajim.20210903.17

Copy | Download

ACS Style

Natalya Avtandilovna Raspopina; Shuganov Evgeny Grigoryevich; Salmasi Jean Mustafaevich; Shuganov Altxander Evgenyevich; Popova Elena Nikolaevna, et al. Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. Am. J. Intern. Med. 2021, 9(3), 148-152. doi: 10.11648/j.ajim.20210903.17

Copy | Download

AMA Style

Natalya Avtandilovna Raspopina, Shuganov Evgeny Grigoryevich, Salmasi Jean Mustafaevich, Shuganov Altxander Evgenyevich, Popova Elena Nikolaevna, et al. Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. Am J Intern Med. 2021;9(3):148-152. doi: 10.11648/j.ajim.20210903.17

Copy | Download

@article{10.11648/j.ajim.20210903.17,
  author = {Natalya Avtandilovna Raspopina and Shuganov Evgeny Grigoryevich and Salmasi Jean Mustafaevich and Shuganov Altxander Evgenyevich and Popova Elena Nikolaevna and Subbotina Tatyana Igorevna and Filippova Tamara Vladimirovna},
  title = {Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features},
  journal = {American Journal of Internal Medicine},
  volume = {9},
  number = {3},
  pages = {148-152},
  doi = {10.11648/j.ajim.20210903.17},
  url = {https://doi.org/10.11648/j.ajim.20210903.17},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20210903.17},
  abstract = {Among respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD) are the most common. Considering that the leading clinical symptom of these diseases is bronchial obstruction, as well as a large number of phenotypes in both asthma and COPD, especially when patients have signs of both diseases, problems arise in differential diagnosis. Immune inflammation plays an important pathological role in chronic obstructive pulmonary disease and asthma. Lymphocyte is the principal immune cell capable of recognizing a particular molecular determinant of the organic structure disorder. We aimed to search for specific features of the immune response in these diseases. Therefore, we determined in peripheral blood the relative and absolute content of lymphocytes expressing the CD3, CD4, CD16, CD54, CD56, CD72, HLA-DR, CD95, and CD178 antigens. The study found that low CD8, CD16 and high CD 178 lymphocytes are characteristic of patients with asthma, and high CD8, CD16 and low CD 178 are typical in COPD. Over 4-5 times increase in CD54 is characteristic of asthma, while in COPD the index exceeded the norm by only 50%. An important feature of COPD is a low apoptosis irrespective of the stage of the disease. These immunologic features can be additional criteria for asthma and COPD differentiation.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features
AU  - Natalya Avtandilovna Raspopina
AU  - Shuganov Evgeny Grigoryevich
AU  - Salmasi Jean Mustafaevich
AU  - Shuganov Altxander Evgenyevich
AU  - Popova Elena Nikolaevna
AU  - Subbotina Tatyana Igorevna
AU  - Filippova Tamara Vladimirovna
Y1  - 2021/06/07
PY  - 2021
N1  - https://doi.org/10.11648/j.ajim.20210903.17
DO  - 10.11648/j.ajim.20210903.17
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 148
EP  - 152
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20210903.17
AB  - Among respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD) are the most common. Considering that the leading clinical symptom of these diseases is bronchial obstruction, as well as a large number of phenotypes in both asthma and COPD, especially when patients have signs of both diseases, problems arise in differential diagnosis. Immune inflammation plays an important pathological role in chronic obstructive pulmonary disease and asthma. Lymphocyte is the principal immune cell capable of recognizing a particular molecular determinant of the organic structure disorder. We aimed to search for specific features of the immune response in these diseases. Therefore, we determined in peripheral blood the relative and absolute content of lymphocytes expressing the CD3, CD4, CD16, CD54, CD56, CD72, HLA-DR, CD95, and CD178 antigens. The study found that low CD8, CD16 and high CD 178 lymphocytes are characteristic of patients with asthma, and high CD8, CD16 and low CD 178 are typical in COPD. Over 4-5 times increase in CD54 is characteristic of asthma, while in COPD the index exceeded the norm by only 50%. An important feature of COPD is a low apoptosis irrespective of the stage of the disease. These immunologic features can be additional criteria for asthma and COPD differentiation.
VL  - 9
IS  - 3
ER  -

Copy | Download

Author Information

Natalya Avtandilovna Raspopina

Institute of Clinical Sciences, Sechenov First Moscow State Medical University of Ministry of Health of Russia (Sechenov University), Moscow, Russia
Shuganov Evgeny Grigoryevich

Department of Therapy, State Budgetary Institution Moscow Regional Research and Clinical Institute n. a. M. F. Vladimirsky. Moscow, Russia
Salmasi Jean Mustafaevich

Pirogov Russian National Research Medical University (RNRMU) of Ministry of Health of Russia, Moscow, Russia
Shuganov Altxander Evgenyevich

Department of Therapy, State Budgetary Institution Moscow Regional Research and Clinical Institute n. a. M. F. Vladimirsky. Moscow, Russia
Popova Elena Nikolaevna

Institute of Clinical Sciences, Sechenov First Moscow State Medical University of Ministry of Health of Russia (Sechenov University), Moscow, Russia
Subbotina Tatyana Igorevna

nstitute of Clinical Sciences, Sechenov First Moscow State Medical University of Ministry of Health of Russia (Sechenov University), Moscow, Russia
Filippova Tamara Vladimirovna

nstitute of Clinical Sciences, Sechenov First Moscow State Medical University of Ministry of Health of Russia (Sechenov University), Moscow, Russia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Natalya Avtandilovna Raspopina, Shuganov Evgeny Grigoryevich, Salmasi Jean Mustafaevich, Shuganov Altxander Evgenyevich, Popova Elena Nikolaevna, et al. (2021). Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. American Journal of Internal Medicine, 9(3), 148-152. https://doi.org/10.11648/j.ajim.20210903.17

Copy | Download

ACS Style

Natalya Avtandilovna Raspopina; Shuganov Evgeny Grigoryevich; Salmasi Jean Mustafaevich; Shuganov Altxander Evgenyevich; Popova Elena Nikolaevna, et al. Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. Am. J. Intern. Med. 2021, 9(3), 148-152. doi: 10.11648/j.ajim.20210903.17

Copy | Download

AMA Style

Natalya Avtandilovna Raspopina, Shuganov Evgeny Grigoryevich, Salmasi Jean Mustafaevich, Shuganov Altxander Evgenyevich, Popova Elena Nikolaevna, et al. Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features. Am J Intern Med. 2021;9(3):148-152. doi: 10.11648/j.ajim.20210903.17

Copy | Download

@article{10.11648/j.ajim.20210903.17,
  author = {Natalya Avtandilovna Raspopina and Shuganov Evgeny Grigoryevich and Salmasi Jean Mustafaevich and Shuganov Altxander Evgenyevich and Popova Elena Nikolaevna and Subbotina Tatyana Igorevna and Filippova Tamara Vladimirovna},
  title = {Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features},
  journal = {American Journal of Internal Medicine},
  volume = {9},
  number = {3},
  pages = {148-152},
  doi = {10.11648/j.ajim.20210903.17},
  url = {https://doi.org/10.11648/j.ajim.20210903.17},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20210903.17},
  abstract = {Among respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD) are the most common. Considering that the leading clinical symptom of these diseases is bronchial obstruction, as well as a large number of phenotypes in both asthma and COPD, especially when patients have signs of both diseases, problems arise in differential diagnosis. Immune inflammation plays an important pathological role in chronic obstructive pulmonary disease and asthma. Lymphocyte is the principal immune cell capable of recognizing a particular molecular determinant of the organic structure disorder. We aimed to search for specific features of the immune response in these diseases. Therefore, we determined in peripheral blood the relative and absolute content of lymphocytes expressing the CD3, CD4, CD16, CD54, CD56, CD72, HLA-DR, CD95, and CD178 antigens. The study found that low CD8, CD16 and high CD 178 lymphocytes are characteristic of patients with asthma, and high CD8, CD16 and low CD 178 are typical in COPD. Over 4-5 times increase in CD54 is characteristic of asthma, while in COPD the index exceeded the norm by only 50%. An important feature of COPD is a low apoptosis irrespective of the stage of the disease. These immunologic features can be additional criteria for asthma and COPD differentiation.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Chronic Obstructive Pulmonary Disease and Asthma Differentiation by Immunologic Features
AU  - Natalya Avtandilovna Raspopina
AU  - Shuganov Evgeny Grigoryevich
AU  - Salmasi Jean Mustafaevich
AU  - Shuganov Altxander Evgenyevich
AU  - Popova Elena Nikolaevna
AU  - Subbotina Tatyana Igorevna
AU  - Filippova Tamara Vladimirovna
Y1  - 2021/06/07
PY  - 2021
N1  - https://doi.org/10.11648/j.ajim.20210903.17
DO  - 10.11648/j.ajim.20210903.17
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 148
EP  - 152
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20210903.17
AB  - Among respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD) are the most common. Considering that the leading clinical symptom of these diseases is bronchial obstruction, as well as a large number of phenotypes in both asthma and COPD, especially when patients have signs of both diseases, problems arise in differential diagnosis. Immune inflammation plays an important pathological role in chronic obstructive pulmonary disease and asthma. Lymphocyte is the principal immune cell capable of recognizing a particular molecular determinant of the organic structure disorder. We aimed to search for specific features of the immune response in these diseases. Therefore, we determined in peripheral blood the relative and absolute content of lymphocytes expressing the CD3, CD4, CD16, CD54, CD56, CD72, HLA-DR, CD95, and CD178 antigens. The study found that low CD8, CD16 and high CD 178 lymphocytes are characteristic of patients with asthma, and high CD8, CD16 and low CD 178 are typical in COPD. Over 4-5 times increase in CD54 is characteristic of asthma, while in COPD the index exceeded the norm by only 50%. An important feature of COPD is a low apoptosis irrespective of the stage of the disease. These immunologic features can be additional criteria for asthma and COPD differentiation.
VL  - 9
IS  - 3
ER  -

Copy | Download